NanoStore: A concept for logistical improvements of compound handling in high-throughput screening

被引:13
作者
Benson, N
Boyd, HF
Everett, JR
Fries, J
Gribbon, P
Haque, N
Henco, K
Jessen, T
Martin, WH
Mathewson, TJ
Sharp, RE
Spencer, RW
Stuhmeier, F
Wallace, MS
Winkler, D
机构
[1] Pfizer Global Res & Dev, Exploratory Med Sci, Groton, CT 06340 USA
[2] Pfizer Global Res & Dev, Discovery Biol, Sandwich CT13 9NJ, Kent, England
[3] Pfizer Global Res & Dev, Med Technol, Sandwich CT13 9NJ, Kent, England
[4] Evotec OAI, Drug Discovery Serv, Hamburg, Germany
关键词
assay miniaturization; ultra-high-throughput screening; compound storage and recovery; 1536-well and 2080-well NanoCarrier (TM);
D O I
10.1177/1087057105277234
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Small molecule screening, the systematic encounter of biology space with chemical space, has provoked the emergence of a whole industry that recreates itself by constant iterative improvements to this process. The authors describe an approach to tackle the problem for one of the most time-consuming steps in the execution of a screening campaign, namely, the reformatting of high-throughput screening test compounds from master plates to daughter assay plates used in the execution of the screen. Through an engineered storage procedure, they prepare plates ahead of the screening process with the respective compounds in a ready-to-use format. They show the biological inertness of the method and how it facilitates efficient recovery of compound activity. This uncoupling of normally interconnected processes provides time and compound savings, avoids repeated freeze-thaw cycles of compound solutions, and removes the problems associated with the DMSO sensitivity of certain assays types.
引用
收藏
页码:573 / 580
页数:8
相关论文
共 16 条
  • [1] Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: Synthesis and structure-activity relationships
    Adam, JM
    Bennett, DJ
    Bom, A
    Clark, JK
    Feilden, H
    Hutchinson, EJ
    Palin, R
    Prosser, A
    Rees, DC
    Rosair, GM
    Stevenson, D
    Tarver, GJ
    Zhang, MQ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1806 - 1816
  • [2] A homogeneous scintillation proximity format for monitoring the activity of recombinant human long-chain-fatty-acyl-CoA synthetase 5
    Bembenek, ME
    Roy, R
    Li, P
    Chee, L
    Jain, S
    Parsons, T
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2004, 2 (03) : 300 - 307
  • [3] Characterization of the kinase domain of the ephrin-B3 receptor tyrosine kinase using a scintillation proximity assay
    Bembenek, ME
    Schmidt, S
    Li, P
    Morawiak, J
    Prack, A
    Jain, S
    Roy, R
    Parsons, T
    Chee, L
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (04) : 555 - 563
  • [4] Bom A, 2002, ANGEW CHEM INT EDIT, V41, P266
  • [5] Studies on repository compound stability in DMSO under various conditions
    Cheng, XH
    Hochlowski, J
    Tang, H
    Hepp, D
    Beckner, C
    Kantor, S
    Schmitt, R
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (03) : 292 - 304
  • [6] Miniaturization of cell-based β-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors
    Chin, J
    Adams, AD
    Bouffard, A
    Green, A
    Lacson, RG
    Smith, T
    Fischer, PA
    Menke, JG
    Sparrow, CP
    Mitnaul, LJ
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (06) : 777 - 787
  • [7] The effect of freeze/thaw cycles on the stability of compounds in DMSO
    Kozikowski, BA
    Burt, TM
    Tirey, DA
    Williams, LE
    Kuzmak, BR
    Stanton, DT
    Morand, KL
    Nelson, SL
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (02) : 210 - 215
  • [8] CALCULATING LOG P(OCT) FROM STRUCTURES
    LEO, AJ
    [J]. CHEMICAL REVIEWS, 1993, 93 (04) : 1281 - 1306
  • [9] LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61
  • [10] MORIGUCHI I, 1994, CHEM PHARM BULL, V42, P976